Yes, provided any payments to the business associate do not exceed the fair market value of its services. See paragraph (2)(i) of the definition of “marketing” at 45 CFR 164.501. The payments may be made by a pharmaceutical manufacturer through a covered entity to the business associate, or directly to the business associate, that is acting on behalf of the covered entity to assist in making the refill reminder or other communication describing the manufacturer’s product.